Skip to main content
All lobbying filings

HEALTHCARE LEADERSHIP COUNCIL

Lobbying for HEALTHCARE LEADERSHIP COUNCIL

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $200,000.00 expenses · posted Jul 14, 2026

Official filing document

 Bills named in this filing 14
  • HR 2213
    Medical Supply Chain Resiliency Act
  • S 988
    Women's Retirement Protection Act
  • HR 2332
    SHARE Act of 2025
  • S 1101
    SHARE Act of 2025
  • HR 8413
    SECURE Data Act
  • HR 8659
    Nursing is a Professional Degree Act
  • S 4568
    Nursing is a Professional Degree Act
  • S 3097
    Health Information Privacy Reform Act
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • HR 3164
    Ensuring Community Access to Pharmacist Services Act
  • S 2426
    Equitable Community Access to Pharmacist Services Act
  • HR 4731
    Resident Physician Shortage Reduction Act of 2025
  • S 2439
    Resident Physician Shortage Reduction Act of 2025
  • HR 8261
    Chronic Care Management Improvement Act of 2026
 Lobbying activity 2
Health Issues

H.R. 2213/S. 988, Medical Supply Chain Resilience Act H.R. 2332/S. 1101, States Handling Access to Reciprocity for Employment Act H.R. 8413, Securing and Establishing Consumer Uniform Rights and Enforcement over Data Act H.R. 8659/S. 4568, Nursing is a Professional Degree Act S. 3097, Health Information Privacy Reform Act S.Amdt. 5159, To reduce the price of prescription drugs in the United States by more than 50 percent by adopting Most Favored Nation drug pricing so that the American people pay no more for prescription drugs than Europeans or Canadian Regulatory Advocacy U.S. Department of Health and Human Services, Centers for Medicare & Medicaid Services Request for Information Related to Comprehensive Regulations to Uncover Suspicious Healthcare (CMS-6098-NC) U.S Department of Health and Human Services, Centers for Medicare & Medicaid Services Interoperability Standards and Prior Authorization for Drugs Proposed Rule (CMS-0062-P) U.S. Department of Health and Human Services Vaccine Injury Compensation Program (VICP) U.S. Department of Commerce, National Institute for Standards and Technology AI-Driven Cybersecurity Risk and Secure & AI-Ready America Action Plan The White House Executive Order 14409: Promoting Advanced Artificial Intelligence Innovation and Security

Medicare/Medicaid

H.R.1, One Big Beautiful Bill Act H.R. 3164/S. 2426, Main Street Pharmacy Access Act H.R. 4731/S. 2439, Resident Physician Shortage Reduction Act H.R. 8261, Chronic Care Management Improvement Act U.S. Department of Health and Human Services, Centers for Medicare & Medicaid Services Request for Information Related to Comprehensive Regulations to Uncover Suspicious Healthcare (CMS-6098-NC) U.S Department of Health and Human Services, Centers for Medicare & Medicaid Services Interoperability Standards and Prior Authorization for Drugs Proposed Rule (CMS-0062-P) U.S. Department of Health and Human Services Vaccine Injury Compensation Program (VICP) U.S. Department of Commerce, National Institute for Standards and Technology AI-Driven Cybersecurity Risk and Secure & AI-Ready America Action Plan The White House Executive Order 14409: Promoting Advanced Artificial Intelligence Innovation and Security

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem